Silginer, Manuela

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Marcu, A., Bichmann, L., Kuchenbecker, L., Kowalewski, D. J., Freudenmann, L. K., Backert, L., Mühlenbruch, L., Szolek, A., Lübke, M., Wagner, P., et al. (2021) · Journal for ImmunoTherapy of Cancer

vaccines and immunoinformatics approachesImmunotherapy and Immune Responses

Cited by 250

Immunocytokines are a promising immunotherapeutic approach against glioblastoma

Weiss, T., Puca, E., Silginer, M., Hemmerle, T., Pazahr, S., Bink, A., Weller, M., Neri, D., & Roth, P. (2020) · Science Translational Medicine

Glioma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers

Cited by 133

Biological activity of tumor-treating fields in preclinical glioma models

Silginer, M., Weller, M., Stupp, R., & Roth, P. (2017) · Cell Death & Disease

Glioma Diagnosis and TreatmentElectromagnetic Fields and Biological Effects

Cited by 111